Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use

US7772429B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Gerhard Jaehne · Frankfurt, DE
• Wendelin Frick · Bad Camberg, DE
• Andreas Lindenschmidt · Bad Soden, DE
• Stefanie Flohr · Basel, CH
• Hubert Heuer · Frankfurt am Main, DE
• Hans-Ludwig Schaefer · Frankfurt am Main, DE
• Werner Kramer · Schwandorf, DE
• Eric Galia · Jülich, DE
• Heiner Glombik · Hofheim, DE

Key dates

• Filing date: Mar 26, 2007
• Grant date: Aug 10, 2010
• Expiry date: Jun 9, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D205/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the compound of the formula 1and to its physiologically acceptable salts. The compound is suitable, for example, as a hypolipidemic.